Published date: 14 August 2020

This notice was replaced on 25 November 2020

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Awarded contract (published 25 November 2020)

Awarded contract - This means that the contract has been awarded to a supplier.


Contract summary

Industry

  • Research laboratory services - 73111000

Location of contract

SW1H 0EU

Value of contract

£1,556,400

Procurement reference

CF-0006000D0O000000rwimUAA1

Published date

14 August 2020

Closing date

1 June 2020

Closing time

12am

Contract start date

1 June 2020

Contract end date

31 December 2020

Contract type

Not applicable

Procedure type

Other

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

Description

Reg. 14 of the Public Contracts Regulations 2015 (PCR2015) subjects certain R&D services to its Part 2 public procurement rules if the benefits of the R&D services accrue exclusively to the contracting authority for its use in the conduct of its own affairs, and the service provided is wholly remunerated by the contracting authority.\r
\r
As part of the National Testing Strategy, Pillar 4's surveillance work endeavours to capture a nationwide picture of Covid-19's prevalence amongst the wider UK population.\r
Unlike the other demographic specific studies, the UK Biobank Seroprevalence Study is intended to capture [sero]prevalence data from across the country, both now and over the course of the next 6 months. The data from the study will be sent to DHSC on a weekly basis.\r
DHSC have partnered with the UK Biobank who are project managing the research, given their existing cohort of participants, operational and analytical expertise.\r
UK Biobank aims to collect monthly blood samples and symptom data (via a short questionnaire) from its participants (as well as from their children and grandchildren aged over 18) to enable an assessment of the extent of previous infection with the SARS‐CoV‐2 coronavirus (by measuring blood antibodies) in different locations and age groups across the UK.\r
The aim is to recruit a population-based sub-study from UK Biobank participants and their adult (i.e. aged over 18) children and grandchildren. It is expected that participants will contribute to the study for 6 months (extendable). The duration of the study will be determined by the trajectory of the coronavirus pandemic in the UK.\r
The objective of the study is to determine the extent of previous infection with the coronavirus that causes COVID‐19 (by collecting samples that can be measured for blood antibodies) in a nationally representative sample of the UK population.\r
The UK Biobank funded activities cover participant recruitment, sample collection, sample processing and storage, and provision of samples to the University of Oxford for sample assay to measure blood antibodies and reporting of infection rates based on returned quantitative assay data.\r
The assay and associated costs are outside of the scope of funding to UK Biobank and are the subject of this contract.

More information

Links

Award information

Awarded date

1 June 2020

Contract start date

1 June 2020

Contract end date

31 December 2020

Total value of contract

£1,556,400

This contract was awarded to 1 supplier.

University of Oxford

Address

Wellington Square OX1 2JD

Reference

None

About the buyer

Contact name

Procurement Operations

Address

39 Victoria Street
London
SW1H 0EU
GB

Email

Procurement.Operations@dhsc.gov.uk